Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers shortlisted for Young Investigator Award, with three wins

RDM researchers have been making their presence felt at the European Society of Cardiology conference this year,  pictured are (left to right) Drs. Naveed Akbar, Jillian Simon, Parag Gajendragadkar, Betty Raman and Evangelos Oikonomou, all of whom were shortlisted for this year's Young Investigator Award. The annual meeting has around 11,000 abstracts submitted, 4,500 for the Young Investigator Awards, which are decided by blinded review from independent judges, with the four top-scoring abstracts being selected for presentation.

After this intense competition, Dr Raman went on to win the Coronary Pathophysiology and Microcirculation Award, while Dr Oikonomou won the clinical research Young Investigator Award, and Dr Gajendragadkar won the population science Young Investigator Award. Drs Akbar and Simon were the runners-up in the Basic Science and Coronary Pathophysiology category. 

Many congratulations to all our young scientists: very well done!

 

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.